Horan Securities’s Asensus Surgical, Inc. ASXC Stock Holding History

Horan Securities’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-331	Closed	-$167	–	707
2023 Q2	$167	Sell	331 -73	-18%	-$44	﹤0.01%	699
2023 Q1	$266	Hold	404	–	–	﹤0.01%	703
2022 Q4	$140	Hold	404	–	–	﹤0.01%	766
2022 Q3	$0	Hold	404	–	–	﹤0.01%	824
2022 Q2	$0	Hold	404	–	–	﹤0.01%	752
2022 Q1	$0	Hold	404	–	–	﹤0.01%	560
2021 Q4	$0	Buy	+404	New	+$624	﹤0.01%	543
2021 Q2	$1K	Hold	404	–	–	﹤0.01%	467
2021 Q1	$1K	Hold	404	–	–	﹤0.01%	408
2020 Q4	$0	Hold	404	–	–	﹤0.01%	452
2020 Q3	$0	Hold	404	–	–	﹤0.01%	404
2020 Q2	$0	Hold	404	–	–	﹤0.01%	385
2020 Q1	$0	Buy	+404	New	+$422	﹤0.01%	291
2019 Q4	–	Sell	-523	Closed	-$4K	–	238
2019 Q3	$4K	Hold	523	–	–	﹤0.01%	216
2019 Q2	$9K	Hold	523	–	–	0.01%	188
2019 Q1	$16K	Hold	523	–	–	0.02%	123
2018 Q4	$18K	Hold	523	–	–	0.02%	111
2018 Q3	$30K	Hold	523	–	–	0.03%	77
2018 Q2	$33K	Buy	+523	New	+$19K	0.03%	76

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $100M AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Horan Securities's ASXC Position: Q3 2023 in Review

Horan Securities sold out of Asensus Surgical, Inc. (ASXC) in Q3 2023, closing a stake of 331 shares — an estimated $167 sold.

Horan Securities first reported a position in ASXC in Q2 2018 and held it in 19 quarters. The position peaked at $33K in Q2 2018. 68 funds tracked by Wall St. Rank hold ASXC as of Q3 2023.

Horan Securities reported no remaining Asensus Surgical, Inc. position as of Q3 2023 after selling out during the quarter.
Horan Securities sold 331 Asensus Surgical, Inc. shares in Q3 2023, an estimated $167.
Horan Securities first reported a position in Asensus Surgical, Inc. in Q2 2018 and held it in 19 quarters.
Horan Securities's Asensus Surgical, Inc. position peaked at $33K in Q2 2018.
68 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.